Cumberland Pharmaceuticals Inc. Stock News

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today announced the results of a Level 1 Trauma Center study recently published in the Journal of Orthopedic Trauma.

Overall, New Jersey logged 2.5 cases per 10,000.

In a report released yesterday, Andrew D’silva from B.Riley FBR maintained a Buy rating on Intricon (IIN – Research Report),

Cumberland (CPIX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).

Cumberland Pharmaceuticals, Inc. (NASDAQ:CPIX) was the recipient of a large growth in short interest in the month of May. As of May 29th, there was short interest totalling 87,400 shares, a growth of

There’s a lot to be optimistic about in the Technology sector as 3 analysts just weighed in on Iteris (ITI

CUMBERLAND - Nancy E. Budd, 77, of Cumberland Maine, passed away unexpectedly at Maine Medical Center on Saturday May 30, 2020. ...

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peak (Biotech Stocks Hitting 52-week Highs June 3) Arena Pharmaceuticals, Inc. (...

Q4 2019 Cumberland Pharmaceuticals Inc Earnings Call

Cumberland finally has executed on its professed strategy of picking up approved drugs neglected by larger players. The problem is that the strategy hasn't nece

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 27) ADC Therapeutics SA (NYSE:...

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes